Navigation Links
Major international study challenges notions of how genes are controlled in mammals
Date:4/21/2009

This release is available in French.

Scientists at the Omics Science Center (OSC) of the RIKEN Yokohama Institute in Japan along with researchers from McGill University and other institutions worldwide are challenging current notions of how genes are controlled in mammals. Three years of intensive research by members of the international FANTOM consortium will culminate with the publication of several milestone scientific papers in Nature Genetics and other journals on April 20.

FANTOM4, the fourth stage of the Functional Annotation of the Mammalian cDNA collaboration, is led by Dr. Yoshihide Hayashizaki of OSC. Dr. Jose Dostie, a biochemist at McGill's Faculty of Medicine joined the FANTOM4 collaboration in 2007 and is its only Canadian member.

For several years, FANTOM researchers have provided the scientific community with extensive data on the genome of mammals, including detailed information on molecular function, biology and individual cell components. Now, the FANTOM4 stage of the collaboration has culminated in a breakthrough that will alter the way scientists understand transcription, the process of cellular copying and reproduction.

"This study really challenges the way we understand cellular differentiation," explained Dr. Dostie, who participated in the primary FANTOM4 research and also authored a satellite paper for publication in the journal Genome Biology. "The dogma right now is that there are so-called 'master regulators,' a series of protein switches that sit in specific places on the genome and induce genes. This is supposed to lead to a cascade that leads to cellular differentiation.

"The FANTOM4 studies show that this thesis is incorrect and there are no master regulators at all," she continued. "It's not like turning everything on like a switch. Instead, it looks like the expression of some genes needs to be decreased while others are increased in a more subtle, but coordinated way."

FANTOM4 is the first report of a large-scale gene network based on an experimental data-set and is likely to generate considerable excitement in the scientific community. The information is important for life science and medical researchers trying to uncover the processes by which cells undergo conversion or become cancerous. It is also related to controlling the growth and differentiation of stem cells and ensuring their safety for use in regenerative medicine.

"We are proud that we have created groundbreaking research in understanding more about how genes regulate cells at the molecular level and we want to acknowledge all consortium members for their great contribution to the research effort," said Dr. Harukazu Suzuki, scientific co-ordinator of the FANTOM4 consortium.


'/>"/>

Contact: Mark Shainblum
mark.shainblum@mcgill.ca
514-398-2189
McGill University
Source:Eurekalert

Related biology news :

1. Major aspergillus genomics supplement published by journal Fungal Genetics and Biology
2. Source of major health benefits in olive oil revealed
3. A missing enzyme conveys major heart protection in pre-clinical work
4. Major NSF grant boosts UNH research on hormonal genomics
5. Rising sea levels set to have major impacts around the world
6. Cellulosic biofuel technology will generate low-cost green fuel, says major study
7. La Jolla Institute signs exclusive license agreement with Medimmune on major asthma discovery
8. NJIT to host major biomedical engineering showcase and career fair
9. Major step for drug discovery and diagnostics
10. Forsyth scientist receives major grant to support rapid, accurate, affordable test for tuberculosis
11. Foretelling a major meltdown
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2016)... 2016 Research and Markets has ... Market 2016-2020"  report to their offering.  , ,     ... The analysts forecast the global multimodal biometrics market ... the period 2016-2020.  Multimodal biometrics is ... as the healthcare, BFSI, transportation, automotive, and government ...
(Date:4/14/2016)... 14, 2016 BioCatch ™, ... today announced the appointment of Eyal Goldwerger ... Goldwerger,s leadership appointment comes at a time ... the deployment of its platform at several of the ... which discerns unique cognitive and physiological factors, is a ...
(Date:3/29/2016)... 2016 LegacyXChange, Inc. (OTC: ... SelectaDNA/CSI Protect are pleased to announce our successful effort ... variety of writing instruments, ensuring athletes signatures against counterfeiting ... from athletes on LegacyXChange will be assured of ongoing ... Bill Bollander , CEO states, "By ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... , June 27, 2016   Ginkgo Bioworks , ... industrial engineering, was today awarded as one of ... of the world,s most innovative companies. Ginkgo Bioworks ... for the real world in the nutrition, health ... work directly with customers including Fortune 500 companies ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Researchers at the ... commonly-identified miRNAs in people with peritoneal or pleural mesothelioma. Their findings are the subject ... it now. , Diagnostic biomarkers are signposts in the blood, lung fluid or ...
(Date:6/23/2016)... June 23, 2016 /PRNewswire/ - FACIT has announced ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" ... commercialization of a portfolio of first-in-class WDR5 inhibitors ... such as WDR5 represent an exciting class of ... precision medicine for cancer patients. Substantial advances have ...
(Date:6/23/2016)... Prostate Cancer Foundation (PCF) is pleased to announce 24 new Young Investigator ... Members of the Class of 2016 were selected from a pool of 128 ... About the Class of 2016 PCF Young Investigators ... ... ...
Breaking Biology Technology: